Indian Immunologicals Partners with ICMR for Clinical Development of Zika Vaccine0
- Uncategorized
- September 14, 2024
Hyderabad: Indian Immunologicals Limited (IIL) has signed a Memorandum of Association (MoA) with the Indian Council of Medical Research (ICMR) to advance the clinical development of a Zika vaccine. Under this agreement, ICMR will cover the costs for the Phase I clinical trials, including the expenses for conducting, investigating, and monitoring the trials at ICMR
READ MORE










